Dr. Reddy's Labs Files 6-K, Submits 20-F Report
Ticker: RDY · Form: 6-K · Filed: Sep 30, 2024 · CIK: 1135951
Sentiment: neutral
Topics: reporting, annual-report, foreign-private-issuer
TL;DR
DRL filed a 6-K on 9/30/24, confirming their 20-F annual report submission.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 30, 2024, to report information as a foreign private issuer. The filing indicates the company is submitting its annual report under cover of Form 20-F. The company's principal executive office is located in Hyderabad, Telangana, India.
Why It Matters
This filing is a routine disclosure for foreign private issuers, confirming their adherence to reporting requirements and providing an update on their annual report submission.
Risk Assessment
Risk Level: low — This is a routine administrative filing for a foreign private issuer and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- 20240930 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Cover
- Hyderabad, Telangana, India (location) — Principal Executive Office
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is filed by Dr. Reddy's Laboratories Ltd. as a foreign private issuer to report information, specifically indicating the submission of their annual report under cover of Form 20-F.
When was this Form 6-K filed?
The Form 6-K was filed on September 30, 2024.
Where is Dr. Reddy's Laboratories Ltd.'s principal executive office located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or Form 40-F?
The filing indicates that Dr. Reddy's Laboratories Ltd. files annual reports under cover of Form 20-F.
What is the SEC file number for Dr. Reddy's Laboratories Ltd.?
The SEC file number for Dr. Reddy's Laboratories Ltd. is 001-15182.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-09-30 06:54:59
Filing Documents
- drr0676_6k.htm (6-K) — 14KB
- drr0676_ex99-1.htm (EX-99.1) — 9KB
- drr0676_ex99-1img01.jpg (GRAPHIC) — 7KB
- drr0676_ex99-1img02.jpg (GRAPHIC) — 6KB
- 0001575872-24-001038.txt ( ) — 42KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: September 30, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3